NYSE:MMS - MAXIMUS Stock Price, News, & Analysis

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

MAXIMUS declared a quarterly dividend on Thursday, January 10th. Investors of record on Friday, February 15th will be given a dividend of $0.25 per share on Thursday, February 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date is Thursday, February 14th. View MAXIMUS's Dividend History.

MAXIMUS declared that its Board of Directors has approved a stock buyback program on Monday, June 25th 2018, which allows the company to buyback $200,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase up to 4.9% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's board believes its stock is undervalued.

MAXIMUS, Inc. (NYSE:MMS) issued its quarterly earnings results on Thursday, February, 7th. The health services provider reported $0.86 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.80 by $0.06. The health services provider earned $664.60 million during the quarter, compared to the consensus estimate of $672.08 million. MAXIMUS had a return on equity of 20.09% and a net margin of 8.94%. The firm's revenue for the quarter was up 6.7% on a year-over-year basis. During the same period last year, the company earned $0.89 EPS. View MAXIMUS's Earnings History.

MAXIMUS is scheduled to release their next quarterly earnings announcement on Thursday, May 9th 2019. View Earnings Estimates for MAXIMUS.

MAXIMUS issued an update on its FY19 earnings guidance on Thursday, February, 7th. The company provided EPS guidance of $3.55 to $3.75 for the period, compared to the Thomson Reuters consensus estimate of $3.63. The company issued revenue guidance of $2.93 billion to $3.00 billion, compared to the consensus revenue estimate of $2.95 billion.MAXIMUS also updated its FY 2019 guidance to $3.55-3.75 EPS.

1 analysts have issued 1-year target prices for MAXIMUS's shares. Their forecasts range from $67.00 to $81.00. On average, they anticipate MAXIMUS's share price to reach $74.00 in the next year. This suggests a possible upside of 0.3% from the stock's current price. View Analyst Price Targets for MAXIMUS.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.

Media stories about MMS stock have trended positive this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. MAXIMUS earned a news impact score of 2.3 on InfoTrie's scale. They also assigned media coverage about the health services provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future.

Some companies that are related to MAXIMUS include Ctrip.Com International (CTRP), Total System Services (TSS), Mercadolibre (MELI), Msci (MSCI), CoStar Group (CSGP), Broadridge Financial Solutions (BR), Akamai Technologies (AKAM), Alliance Data Systems (ADS), Nielsen (NLSN), CIELO S A/S (CIOXY), The Western Union (WU), Zillow Group (Z), GrubHub (GRUB), WEX (WEX) and Zillow Group (ZG).

MAXIMUS's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.55%), Victory Capital Management Inc. (6.29%), Mackenzie Financial Corp (2.90%), Oregon Public Employees Retirement Fund (2.60%), Bank of New York Mellon Corp (1.86%) and Northern Trust Corp (1.73%). Company insiders that own MAXIMUS stock include Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.

MMS stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, First Quadrant L P CA, Brown Advisory Inc., D. E. Shaw & Co. Inc., Fort Washington Investment Advisors Inc. OH, Falcon Point Capital LLC, Handelsbanken Fonder AB and Mondrian Investment Partners LTD. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Mark Andrekovich, Paul R Lederer, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.

MMS stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Mackenzie Financial Corp, Ranger Investment Management L.P., Geode Capital Management LLC, Acadian Asset Management LLC, BlackRock Inc., Epoch Investment Partners Inc. and Rhumbline Advisers. View Insider Buying and Selling for MAXIMUS.

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MMS stock can currently be purchased for approximately $73.78.

MAXIMUS has a market capitalization of $4.71 billion and generates $2.39 billion in revenue each year. The health services provider earns $220.75 million in net income (profit) each year or $3.40 on an earnings per share basis. MAXIMUS employs 18,600 workers across the globe.

The official website for MAXIMUS is http://www.maximus.com.

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]